Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $43.8500 (-4.59%) ($43.7200 - $44.8400) on Fri. Jun. 24, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.22% (three month average) | RSI | 52 | Latest Price | $43.8500(-4.59%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -0.3% a day on average for past five trading days. | Weekly Trend | BAX advances 0.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(57%) SPLV(52%) VYM(51%) SPY(50%) IVE(49%) | Factors Impacting BAX price | BAX will decline at least -0.61% in a week (0% probabilities). VIXM(-18%) TLT(-17%) GDXJ(-7%) UUP(-6%) IPO(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.61% (StdDev 1.22%) | Hourly BBV | 0 () | Intraday Trend | -2.2% | | | |
|
Resistance Level | $44.3 | 5 Day Moving Average | $44.94(-2.43%) | 10 Day Moving Average | $44.69(-1.88%) | 20 Day Moving Average | $44.3(-1.02%) | To recent high | -5.5% | To recent low | 9.3% | Market Cap | $22.371b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |